{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:45:11Z","timestamp":1792464311318,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT 1139902"],"award-info":[{"award-number":["GNT 1139902"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017657","name":"Fondation de l'H\u00f4pital G\u00e9n\u00e9ral de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jacig.2024.100354","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:09:58Z","timestamp":1729278598000},"page":"100354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Global differences and risk factors influencing drug hypersensitivity quality of life: A\u00a0multicenter, multiethnic study of drug allergy across 3 continents"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-5032","authenticated-orcid":false,"given":"Ana M.","family":"Copaescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo W.F.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100354_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4199","article-title":"Prevalence, incidence, and sensitization profile of beta-lactam antibiotic allergy in Hong Kong","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2024.100354_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12916-024-03250-0","article-title":"Identifying the most at-risk age-group and longitudinal trends of drug allergy labeling amongst 7.3 million individuals in Hong Kong","volume":"22","author":"Chiang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jacig.2024.100354_bib3","first-page":"29","article-title":"Potential negative effects of antimicrobial allergy labelling on patient care: a systematic review","volume":"71","author":"Wu","year":"2018","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jacig.2024.100354_bib4","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jaip.2024.04.010","article-title":"Prospective, multicenter, head-to-head comparison between allergists versus nonallergists in low-risk penicillin allergy delabeling: effectiveness, safety, and quality of life (HK-DADI2)","volume":"12","author":"Wong","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib5","doi-asserted-by":"crossref","unstructured":"Li TS, Hui HKS, Kan AKC, Yeung MHY, Wong JCY, Chiang V, et\u00a0al. Prospective Assessment of Penicillin Allergy (PAPA): evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese [published online ahead of print April 17, 2023]. Asian Pac J Allergy Immunol. https:\/\/doi.org\/10.12932\/AP-270922-1469.","DOI":"10.12932\/AP-270922-1469"},{"key":"10.1016\/j.jacig.2024.100354_bib6","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK tertiary centre","volume":"7","author":"Siew","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamainternmed.2023.2986","article-title":"Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE Randomized Clinical Trial","volume":"183","author":"Copaescu","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacig.2024.100354_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jaip.2023.03.012","article-title":"Health-related quality of life and mental health in drug hypersensitivity reactions and drug-induced anaphylaxis: a systematic review and meta-analysis","volume":"11","author":"Martini","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2024.100354_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5415\/apallergy.0000000000000020","article-title":"Validation of the Chinese drug hypersensitivity quality of life questionnaire: role of delabeling","volume":"13","author":"Mak","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jacig.2024.100354_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.anai.2010.12.014","article-title":"Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire","volume":"106","author":"Baiardini","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2024.100354_bib12","first-page":"508","article-title":"Cross-cultural adaptation and linguistic validation of the Spanish version of the drug hypersensitivity quality of life questionnaire","volume":"23","author":"Gastaminza","year":"2013","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100354_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12955-021-01749-1","article-title":"Drug Hypersensitivity Quality of Life Questionnaire: validation procedures and first results of the Portuguese version","volume":"19","author":"Dias de Castro","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jacig.2024.100354_bib14","first-page":"129","article-title":"Assessment of validity and reliability of Drug Hypersensitivity Quality of Life Questionnaire: the Dutch experience","volume":"49","author":"Moayeri","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100354_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11136-015-1051-2","article-title":"Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity","volume":"25","author":"Bavbek","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jacig.2024.100354_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/intqhc\/mzy207","article-title":"Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study","volume":"31","author":"Chongpison","year":"2019","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacig.2024.100354_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaip.2024.02.016","article-title":"Enhancing patient-reported outcome measures for drug hypersensitivity: a validated 6-item Quality-of-Life Questionnaire for Patients with Drug Hypersensitivity (DrHy-Q6)","volume":"12","author":"Mak","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/MLR.0b013e31817a835d","article-title":"National health surveys and the behavioral model of health services use","volume":"46","author":"Andersen","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.jacig.2024.100354_bib19","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1111\/all.15725","article-title":"Disparities and inequalities of penicillin allergy in the Asia-Pacific region","volume":"78","author":"Li","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2024.100354_bib20","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.5415\/apallergy.2020.10.e36","article-title":"Diagnostic procedures & practices in drug allergy\/hypersensitivity: a survey of 13 Asian countries","volume":"10","author":"Tang","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jacig.2024.100354_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacig.2024.100354_bib22","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.jaip.2019.05.017","article-title":"Quality of life in patients with allergic reactions to medications: influence of a drug allergy evaluation","volume":"7","author":"Gastaminza","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1742-1241.2003.tb10456.x","article-title":"Why do family doctors prescribe antibiotics for upper respiratory tract infection?","volume":"57","author":"Lam","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacig.2024.100354_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2710.2003.00485.x","article-title":"What are the non-biomedical reasons which make family doctors over-prescribe antibiotics for upper respiratory tract infection in a mixed private\/public Asian setting?","volume":"28","author":"Lam","year":"2003","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jacig.2024.100354_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/qshc.2007.023267","article-title":"Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong","volume":"17","author":"Ng","year":"2008","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.jacig.2024.100354_bib26","first-page":"100322","article-title":"Health literacy of ethnic minority in remote China: precise intervention is needed","volume":"17","author":"Hu","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jacig.2024.100354_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12962-022-00349-0","article-title":"Association between ethnicity and health knowledge among the floating population in China","volume":"20","author":"Han","year":"2022","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.jacig.2024.100354_bib28","doi-asserted-by":"crossref","first-page":"100622","DOI":"10.1016\/j.waojou.2021.100622","article-title":"Experience of the first 1127 COVID-19 vaccine allergy safety patients in Hong Kong\u2014clinical outcomes, barriers to vaccination, and urgency for reform","volume":"15","author":"Chiang","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2024.100354_bib29","doi-asserted-by":"crossref","first-page":"690837","DOI":"10.3389\/falgy.2021.690837","article-title":"Consensus statements on the approach to COVID-19 vaccine allergy safety in Hong Kong","volume":"2","author":"Chiang","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jacig.2024.100354_bib30","first-page":"1","article-title":"The unmet provision of allergy services in Hong Kong impairs capability for allergy prevention\u2014implications for the Asia Pacific region","volume":"37","author":"Lee","year":"2019","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T17:59:23Z","timestamp":1738519163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2772829324001504"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100354","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global differences and risk factors influencing drug hypersensitivity quality of life: A\u00a0multicenter, multiethnic study of drug allergy across 3 continents","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100354"}}